The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Chikungunya vaccine is linked to severe complications in older adults Live virus vaccine caused hospitalizations and two ...

The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus. But the FDA and the Centers ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

An influx of cases could ultimately strain health care systems. Health officials issue urgent warning as deadly tropical disease surges in new region: 'A historic peak' first appeared on The Cool Down ...

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

May 21 (Reuters) - The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya ... of the CDC. Sign up here.